Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $2.35 | Prev. Close $2.37 | Circuit Range N/A |
Day Range $2.35 - $2.39 | Year Range $2.35 - $21.00 | Volume 779 |
Average Traded $2.37 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jan-26 | $2.35 | $2.37 | -11.24% |
28-Jan-26 | $2.61 | $2.67 | -4.30% |
27-Jan-26 | $2.79 | $2.79 | -1.06% |
23-Jan-26 | $2.71 | $2.82 | -0.35% |
22-Jan-26 | $2.76 | $2.83 | +10.76% |
20-Jan-26 | $2.58 | $2.56 | -8.75% |
13-Jan-26 | $2.71 | $2.80 | -0.53% |